BioWorld

May 3, 2007

Array Raises $91M Publicly For Cancer, Inflammation Programs

Array BioPharma Inc. raised $91 million in a public offering of stock, money that will be used to fund development of its broad, early stage pipeline of small-molecule drug candidates for cancer and inflammatory diseases. (BioWorld Today) Read More

Varying FOB Proposals Seem To Signal Compromise In The Works

Specific Starvation Gene Joins Sirtuins As Longevity Target

NeurogesX Lowers Share Price Again, Brings In $44M In IPO

AVI, Ercole Join Technologies To Tackle DMD, Thalassemia

Immunomedics Raises $24M For Anticancer Antibodies

Other News To Note

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for July 21, 2026.

ALN-5288 lowers tau levels in preclinical models

BioWorld Science

Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....

LIT-002 is strong candidate for autism and neuropathic pain

BioWorld Science

Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 21, 2026

New biomarker may improve RSV drug screening

BioWorld

Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...